SCHEMBL5364658

SCHEMBL5364658

Cc1ccc(COC(=O)N2CCC(CNC(=O)c3ccc(O)nc3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 2/20 0.62
TPSD1 Q9BZJ3 2/20 0.62
TPSG1 Q9NRR2 2/20 0.62
F2 P00734 1/20 0.62
PLG P00747 1/20 0.62
PRSS1 P07477 1/20 0.62
PRSS2 P07478 1/20 0.62
PRSS3 P35030 1/20 0.62
GRIN2B Q13224 14/20 0.61
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5360920 0.90 TPSAB1 (0.62) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5369663 0.90 TPSAB1 (0.62) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5368197 0.88 TPSAB1 (0.72) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5363958 0.85 TPSAB1 (0.70) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5361037 0.85 TPSAB1 (0.70) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5361028 0.85 TPSAB1 (0.70) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5371203 0.84 NPC1L1 (0.62) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5359992 0.84 TPSAB1 (0.69) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5369674 0.84 TPSAB1 (0.72) TPSAB1TPSD1TPSG1F2PLG
SCHEMBL5374920 0.84 TPSAB1 (0.66) TPSAB1TPSD1TPSG1F2PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed